Hamdy Ahmed MD 4

What Happened Dr. Hamdy Ahmed, Chief Medical Officer of Curis, converted 50 shares of Series B Convertible Non‑Redeemable Preferred Stock into 66,667 shares of Curis common stock on March 20, 2026. The conversion was automatic and required no additional cash consideration; the filing lists the acquisition of 66,667 common shares and the disposition of 50 derivative (preferred) shares. No per‑share common stock price or total market value at conversion is reported on the Form 4.

Key Details

• Transaction date: March 20, 2026 (reported on Form 4 filed March 23, 2026). Filing appears timely (within required two business days).
• Conversion: 50 Series B Preferred → 66,667 Common Stock (conversion ratio: 1,333.33 common shares per Series B share). Conversion occurred automatically at 5:00 p.m. ET on March 20, 2026.
• Cash/price: Conversion for no additional consideration; Form 4 lists "N/A" for per‑share price and total value.
• Shares owned after transaction: Not disclosed in the filing.
• Footnote: Each "Security" purchased earlier by the reporting person consisted of one Series B Preferred share plus Series A, B and C warrants; those Securities were originally sold at $1,000 per Security to the reporting person.

Context

• This was a conversion of a derivative/preferred security into common stock (not an open‑market buy or sell). The separate Form 4 lines showing a 50‑share disposition (the preferred) and a 66,667‑share acquisition (common) record the same automatic conversion event.
• Because no cash changed hands at conversion, the filing does not by itself indicate a purchase or sale in the market; it records an ownership form change.